Abstract

Platycodi radix (i.e., Platycodon grandiflorum root) products (e.g., tea, cosmetics, and herbal supplements) are popular in East Asian nutraceutical markets due to their reported health benefits and positive consumer perceptions. Platycosides are the key drivers of Platycodi radixes’ biofunctional effects; their nutraceutical and pharmaceutical activities are primarily related to the number and varieties of sugar side-chains. Among the various platycosides, platycodin D is a major saponin that demonstrates various nutraceutical activities. Therefore, the development of a novel technology to increase the total platycodin D content in Platycodi radix extract is important, not only for consumers’ health benefits but also producers’ commercial applications and manufacturing cost reduction. It has been reported that hydrolysis of platycoside sugar moieties significantly modifies the compound’s biofunctionality. Platycodi radix extract naturally contains two major platycodin D precursors (platycoside E and platycodin D3) which can be enzymatically converted to platycodin D via β-d-glucosidase hydrolysis. Despite evidence that platycodin D precursors can be changed to platycodin D in the Platycodi radix plant, there is little research on increasing platycodin D concentrations during processing. In this work, platycodin D levels in Platycodi radix extracts were significantly increased via extracellular Aspergillus usamii β-d-glucosidase (n = 3, p < 0.001). To increase the extracellular β-d-glucosidase activity, A. usamii was cultivated in a culture media containing cellobiose as its major carbon source. The optimal pH and temperature of the fungal β-d-glucosidase were 6.0 and 40.0 °C, respectively. Extracellular A. usamii β-d-glucosidase successfully converted more than 99.9% (w/v, n = 3, p < 0.001) of platycoside E and platycodin D3 into platycodin D within 2 h under optimal conditions. The maximum level of platycodin D was 0.4 mM. Following the biotransformation process, the platycodin D was recovered using preparatory High Performance Liquid Chromatography (HPLC) and applied to in vitro assays to evaluate its quality. Platycodin D separated from the Platycodi radix immediately following the bioconversion process showed significant anti-inflammatory effects from the Lipopolysaccharide (LPS)-induced macrophage inflammatory responses with decreased nitrite and IL-6 production (n = 3, p < 0.001). Taken together, these results provide evidence that biocatalysis of Platycodi radix extracts with A. usamii may be used as an efficient method of platycodin D-enriched extract production and novel Platycodi radix products may thereby be created.

Highlights

  • Platycodi radix (PR), the Platycodon grandiflorum root, has traditionally been used in popular herbal medicine for the prevention and treatment of cold-related symptoms in various East Asian countries [1,2]

  • Previous research has reported that platycodin D reduced the risk of inflammation [10], obesity [11], Hepatitis C viral infection [12], allergy-related diseases [13], tumorigenicity [14] and the development of cancers [15,16,17,18,19]

  • The addition of glucose to microbial media can significantly reduce the production of the desired microbial enzyme (i.e., β-D-glucosidase) due to catabolic repression [31]

Read more

Summary

Introduction

Platycodi radix (PR), the Platycodon grandiflorum root, has traditionally been used in popular herbal medicine for the prevention and treatment of cold-related symptoms (e.g., coughs, phlegm, tonsillitis, asthma and bronchitis) in various East Asian countries [1,2]. Previous research has reported that platycodin D reduced the risk of inflammation [10], obesity [11], Hepatitis C viral infection [12], allergy-related diseases [13], tumorigenicity [14] and the development of cancers (i.e., liver, ovarian, breast, gastric and leukemia) [15,16,17,18,19] These platycodin D studies demonstrated that platycodin D-enriched products can be used to alleviate cold-related symptoms and to prevent chronic and fatal diseases. A technique that efficiently transforms the chemical structures of these precursors without degrading the existing platycodin D would increase the total platycodin D content of PR products Such a technique would contribute to improving the quality of the product and its pharmacological effects

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call